Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.183
Buy
RSI(14)
62.471
Neutral
STOCH(KDJ)(9,3,3)
62.351
Neutral
ATR(14)
1.363
High Vlolatility
CCI(14)
75.805
Neutral
Williams %R
34.962
Buy
TRIX(12,20)
0.607
Sell
StochRSI(14)
39.679
Sell
Search
BioLife Solutions Inc
BLFSAdd to Watchlist
31.280USD
-0.360-1.14%
Close 07-31 16:00（ET）Quotes delayed by 15 min
1.53BMarket Cap
LossP/E TTM
View Detailed Chart
TradingKey ChartIntraday
1m
30m
1h
D
W
M
D
Today
-1.14%
5 Days
+4.34%
1 Month
+11.28%
6 Months
+40.08%
Year to Date
+29.36%
1 Year
+50.35%
Key Figures
31.590Open
31.700High
764.55KVolume
LossP/E TTM
88.59P/E Dynamic
--Dividend TTM
1.61%Turnover Ratio
31.640Prev. Close
31.020Low
16.02MTurnover
LossP/E Static
4.22P/B
0.00%Div Yield TTM
-2.82%ROA
29.62052wk High
0.63Volume Ratio
-20.18MNet Profit
47.55MShares
-0.0622EPS TTM
2.00Beta
-3.09%ROE
17.86052wk Low
2.15%Amplitude
63.31%Gross Margin
1.53BMarket Cap
5.27Reward/Risk
2.63%Risk Rate
TradingKey Stock Score of BioLife Solutions Inc
Currency: USD Updated: 2026-07-31Key Insights
BioLife Solutions Inc's fundamentals are relatively very healthy, and its growth potential is high.Its valuation is considered fairly valued, ranking 11 out of 199 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Hold, with the highest price target at 31.12.In the medium term, the stock price is expected to trend up.Despite a good stock market performance and outperforming fundamentals over the past month, the technicals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
BioLife Solutions Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Negative
BioLife Solutions Inc Highlights
StrengthsRisks
BioLife Solutions, Inc. is a developer and supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 26.84% year-on-year.
Growing
The company is in a growing phase, with the latest annual income totaling USD 96.21M.
Undervalued
The company’s latest PE is -502.49, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 51.34M shares, decreasing 2.40% quarter-over-quarter.
Held by Bill Nygren | OAKMX
Star Investor Bill Nygren | OAKMX holds 454.69K shares of this stock.
Higher Market Activity
The company has more investor interest, with a 20-day turnover ratio of 2.06.
Analyst Rating
Based on
9
analysts
Hold
Current Rating
31.125
Target Price
-0.50%
Upside Space
BioLife Solutions Inc News
More news coming soon, stay tuned...
Earnings Forecast
Analyst Rating
Based on
9
analysts
Hold
Current Rating
31.125
Target Price
-0.50%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
109
Total
7
Median
9
Average
Company name
Ratings
Analysts
BioLife Solutions Inc
BLFS
9
Medtronic PLC
MDT
34
Stryker Corp
SYK
32
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
29
1
2
3
...
22
Indicators
Moving Average
Indicators
Value
Direction
MA5
31.238
Buy
MA10
30.637
Buy
MA20
29.550
Buy
MA50
27.595
Buy
MA100
24.017
Buy
MA200
24.396
Buy
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
BioLife Solutions Inc Info
BioLife Solutions, Inc. is a developer and supplier of cell processing tools and services for the cell and gene therapy (CGT) market. The Company facilitates the commercialization of new therapies by supplying solutions that maintain the health and function of biologic materials during collection, development, manufacturing and distribution. Its CryoStor freeze media and HypoThermosol hypothermic storage media are optimized to preserve cells in the regenerative medicine market. Its Sexton cell processing product line includes human platelet lysates (hPL) for cell expansion. Its CellSeal cryogenic vials, which are rigid containers used in cell and gene therapy (CGT). Its CryoCase cryo-compatible transparent rigid containers are designed for closed-system fill and retrieval, and automated cell processing machines. The Company’s ThawSTAR product line is composed of a family of automated thawing devices for frozen cell and gene therapies packaged in cryovials and cryobags.
Ticker SymbolBLFS
CompanyBioLife Solutions Inc
CEODe Greef (Roderick)
Websitehttps://www.biolifesolutions.com/
Shareholders
Related Instruments
-1.72%
-0.43%
+0.12%
-0.59%
-0.74%
-6.42%
+0.10%
-0.36%
+1.75%
-0.14%
-2.99%
+1.58%
-0.29%
+0.41%
-1.02%
+0.13%
+0.05%
-0.80%
-0.24%
-0.70%Popular Instruments
52742.700
+364.700 (+0.70%)
28525.100
+364.200 (+1.29%)
7531.700
+56.600 (+0.76%)
14605.000
-144.000 (-0.98%)
63313.000
+461.000 (+0.73%)
6398.500
+33.100 (+0.52%)
79.182
-6.752 (-7.86%)
308.910
-24.520 (-7.35%)
200.750
+5.710 (+2.93%)
4060.920
+19.490 (+0.48%)
FAQs
What is the current price of BioLife Solutions Inc (BLFS)?
The current price of BioLife Solutions Inc (BLFS) is 31.28.
What is the symbol of BioLife Solutions Inc?
The ticker symbol of BioLife Solutions Inc is BLFS.
What is the 52-week high of BioLife Solutions Inc?
The 52-week high of BioLife Solutions Inc is 29.62.
What is the 52-week low of BioLife Solutions Inc?
The 52-week low of BioLife Solutions Inc is 17.86.
What is the market capitalization of BioLife Solutions Inc?
The market capitalization of BioLife Solutions Inc is 1.53B.
Is BioLife Solutions Inc (BLFS) currently rated as Buy, Hold, or Sell?
According to analysts, BioLife Solutions Inc (BLFS) has an overall rating of signal_hold, with a price target of 31.12.
What is the Earnings Per Share (EPS TTM) of BioLife Solutions Inc (BLFS)?
The Earnings Per Share (EPS TTM) of BioLife Solutions Inc (BLFS) is -0.10.